Oxotremorine-induced modifications of the behavioral and neuroendocrine responses to formalin pain in male rats

Francesca Capone, Anna Maria Aloisi, Giancarlo Carli, Paola Sacerdote, Flaminia Pavone

Research output: Contribution to journalArticle

Abstract

In the present investigation, the antinociceptive effects of the muscarinic cholinergic agonist, oxotremorine, were evaluated in rats using the formalin test. In Expt. 1, two oxotremorine concentrations (0.1 and 0.2 mg/kg) and two administration times (15 and 1 min before formalin injection) were chosen. All spontaneous and formalin-evoked behavioral responses were considered. In Expt. 2, only the higher concentration of oxotremorine (0.2 mg/kg) was administered 15 or 1 min before the formalin test. The animals were killed 15, 30 or 60 min after formalin treatment. Blood was collected from the trunk to determine corticosterone plasma levels. Some brain areas (hypothalamus, septum and periaqueductal gray matter) were dissected for determination of the β-endorphin content. Oxotremorine induced a dose- and time-dependent reduction of all formalin-evoked responses: licking was decreased during both the first and second phases of the formalin test, flexing was decreased during the second phase by the higher concentration only and paw-jerk was decreased during the first phase by both concentrations. Rearing and line-crossing were significantly decreased by oxotremorine while exploratory activity was only partially reduced; self- grooming was increased. These effects on exploratory activity and self- grooming were abolished by formalin treatment. β-endorphin content in the septum was increased by oxotremorine administered 15 min, but not 1 min, before formalin-treatment. β-endorphin in the hypothalamus increased in all formalin-treated groups independently of oxotremorine administration. These results confirm, and extend to tonic pain, the analgesic effect exerted by oxotremorine on phasic responses. Because of the different effects on each formalin-induced response, they also indicate both spinal and supraspinal CNS sites of action.

Original languageEnglish
Pages (from-to)292-300
Number of pages9
JournalBrain Research
Volume830
Issue number2
DOIs
Publication statusPublished - Jun 5 1999

Fingerprint

Oxotremorine
Formaldehyde
Pain
Endorphins
Pain Measurement
Grooming
Hypothalamus
Muscarinic Agonists
Periaqueductal Gray
Corticosterone
Analgesics
Therapeutics
Injections
Brain

Keywords

  • β- Endorphin
  • Analgesia
  • Behavior
  • Corticosterone
  • Formalin test
  • Muscarinic receptor

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Oxotremorine-induced modifications of the behavioral and neuroendocrine responses to formalin pain in male rats. / Capone, Francesca; Aloisi, Anna Maria; Carli, Giancarlo; Sacerdote, Paola; Pavone, Flaminia.

In: Brain Research, Vol. 830, No. 2, 05.06.1999, p. 292-300.

Research output: Contribution to journalArticle

Capone, Francesca ; Aloisi, Anna Maria ; Carli, Giancarlo ; Sacerdote, Paola ; Pavone, Flaminia. / Oxotremorine-induced modifications of the behavioral and neuroendocrine responses to formalin pain in male rats. In: Brain Research. 1999 ; Vol. 830, No. 2. pp. 292-300.
@article{52bd3198ac104599aac784a61b8beb77,
title = "Oxotremorine-induced modifications of the behavioral and neuroendocrine responses to formalin pain in male rats",
abstract = "In the present investigation, the antinociceptive effects of the muscarinic cholinergic agonist, oxotremorine, were evaluated in rats using the formalin test. In Expt. 1, two oxotremorine concentrations (0.1 and 0.2 mg/kg) and two administration times (15 and 1 min before formalin injection) were chosen. All spontaneous and formalin-evoked behavioral responses were considered. In Expt. 2, only the higher concentration of oxotremorine (0.2 mg/kg) was administered 15 or 1 min before the formalin test. The animals were killed 15, 30 or 60 min after formalin treatment. Blood was collected from the trunk to determine corticosterone plasma levels. Some brain areas (hypothalamus, septum and periaqueductal gray matter) were dissected for determination of the β-endorphin content. Oxotremorine induced a dose- and time-dependent reduction of all formalin-evoked responses: licking was decreased during both the first and second phases of the formalin test, flexing was decreased during the second phase by the higher concentration only and paw-jerk was decreased during the first phase by both concentrations. Rearing and line-crossing were significantly decreased by oxotremorine while exploratory activity was only partially reduced; self- grooming was increased. These effects on exploratory activity and self- grooming were abolished by formalin treatment. β-endorphin content in the septum was increased by oxotremorine administered 15 min, but not 1 min, before formalin-treatment. β-endorphin in the hypothalamus increased in all formalin-treated groups independently of oxotremorine administration. These results confirm, and extend to tonic pain, the analgesic effect exerted by oxotremorine on phasic responses. Because of the different effects on each formalin-induced response, they also indicate both spinal and supraspinal CNS sites of action.",
keywords = "β- Endorphin, Analgesia, Behavior, Corticosterone, Formalin test, Muscarinic receptor",
author = "Francesca Capone and Aloisi, {Anna Maria} and Giancarlo Carli and Paola Sacerdote and Flaminia Pavone",
year = "1999",
month = "6",
day = "5",
doi = "10.1016/S0006-8993(99)01419-5",
language = "English",
volume = "830",
pages = "292--300",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Oxotremorine-induced modifications of the behavioral and neuroendocrine responses to formalin pain in male rats

AU - Capone, Francesca

AU - Aloisi, Anna Maria

AU - Carli, Giancarlo

AU - Sacerdote, Paola

AU - Pavone, Flaminia

PY - 1999/6/5

Y1 - 1999/6/5

N2 - In the present investigation, the antinociceptive effects of the muscarinic cholinergic agonist, oxotremorine, were evaluated in rats using the formalin test. In Expt. 1, two oxotremorine concentrations (0.1 and 0.2 mg/kg) and two administration times (15 and 1 min before formalin injection) were chosen. All spontaneous and formalin-evoked behavioral responses were considered. In Expt. 2, only the higher concentration of oxotremorine (0.2 mg/kg) was administered 15 or 1 min before the formalin test. The animals were killed 15, 30 or 60 min after formalin treatment. Blood was collected from the trunk to determine corticosterone plasma levels. Some brain areas (hypothalamus, septum and periaqueductal gray matter) were dissected for determination of the β-endorphin content. Oxotremorine induced a dose- and time-dependent reduction of all formalin-evoked responses: licking was decreased during both the first and second phases of the formalin test, flexing was decreased during the second phase by the higher concentration only and paw-jerk was decreased during the first phase by both concentrations. Rearing and line-crossing were significantly decreased by oxotremorine while exploratory activity was only partially reduced; self- grooming was increased. These effects on exploratory activity and self- grooming were abolished by formalin treatment. β-endorphin content in the septum was increased by oxotremorine administered 15 min, but not 1 min, before formalin-treatment. β-endorphin in the hypothalamus increased in all formalin-treated groups independently of oxotremorine administration. These results confirm, and extend to tonic pain, the analgesic effect exerted by oxotremorine on phasic responses. Because of the different effects on each formalin-induced response, they also indicate both spinal and supraspinal CNS sites of action.

AB - In the present investigation, the antinociceptive effects of the muscarinic cholinergic agonist, oxotremorine, were evaluated in rats using the formalin test. In Expt. 1, two oxotremorine concentrations (0.1 and 0.2 mg/kg) and two administration times (15 and 1 min before formalin injection) were chosen. All spontaneous and formalin-evoked behavioral responses were considered. In Expt. 2, only the higher concentration of oxotremorine (0.2 mg/kg) was administered 15 or 1 min before the formalin test. The animals were killed 15, 30 or 60 min after formalin treatment. Blood was collected from the trunk to determine corticosterone plasma levels. Some brain areas (hypothalamus, septum and periaqueductal gray matter) were dissected for determination of the β-endorphin content. Oxotremorine induced a dose- and time-dependent reduction of all formalin-evoked responses: licking was decreased during both the first and second phases of the formalin test, flexing was decreased during the second phase by the higher concentration only and paw-jerk was decreased during the first phase by both concentrations. Rearing and line-crossing were significantly decreased by oxotremorine while exploratory activity was only partially reduced; self- grooming was increased. These effects on exploratory activity and self- grooming were abolished by formalin treatment. β-endorphin content in the septum was increased by oxotremorine administered 15 min, but not 1 min, before formalin-treatment. β-endorphin in the hypothalamus increased in all formalin-treated groups independently of oxotremorine administration. These results confirm, and extend to tonic pain, the analgesic effect exerted by oxotremorine on phasic responses. Because of the different effects on each formalin-induced response, they also indicate both spinal and supraspinal CNS sites of action.

KW - β- Endorphin

KW - Analgesia

KW - Behavior

KW - Corticosterone

KW - Formalin test

KW - Muscarinic receptor

UR - http://www.scopus.com/inward/record.url?scp=0033526622&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033526622&partnerID=8YFLogxK

U2 - 10.1016/S0006-8993(99)01419-5

DO - 10.1016/S0006-8993(99)01419-5

M3 - Article

C2 - 10366686

AN - SCOPUS:0033526622

VL - 830

SP - 292

EP - 300

JO - Brain Research

JF - Brain Research

SN - 0006-8993

IS - 2

ER -